-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Syndax Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q1 2025.
- Syndax Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $10.4M, a 16.6% increase year-over-year.
- Syndax Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $44.5M, a 32.4% increase year-over-year.
- Syndax Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2024 was $43M, a 39% increase from 2023.
- Syndax Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $31M, a 93.2% increase from 2022.
- Syndax Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $16M, a 20.3% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)